glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with etorphine in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (etorphine) | Trials (etorphine) | Recent Studies (post-2010) (etorphine) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 798 | 23 | 63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, J; Chen, B; Duttaroy, A; Sehba, F; Shah, S; Yoburn, BC | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and etorphine
| Article | Year |
|---|---|
In vivo homologous regulation of mu-opioid receptor gene expression in the mouse.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Etorphine; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; Infusion Pumps, Implantable; Male; Mice; Peptide Fragments; Rats; Receptors, Opioid, mu | 1997 |